Los Angeles Capital Management
BIOA

Los Angeles Capital Management’s BioAge Labs BIOA Stock Holding History

Los Angeles Capital Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$593K Sell
33,899
-6,489
-16% -$125K ﹤0.01% 816
2025
Q4 		$312K Sell
40,388
-80,541
-67% -$714K ﹤0.01% 1079
2025
Q3 		$711K Buy
+120,929
New +$566K ﹤0.01% 809

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Los Angeles Capital Management's BIOA Position: Q1 2026 in Review

Los Angeles Capital Management reduced its BioAge Labs (BIOA) stake by 16% in Q1 2026, selling an estimated $125K and leaving 33,899 shares worth $593K. The position accounts for ﹤0.01% of the portfolio, ranked #816.

Los Angeles Capital Management first reported a position in BIOA in Q3 2025 and has held it in 3 quarters since. The position peaked at $711K in Q3 2025. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Los Angeles Capital Management held 33,899 shares of BioAge Labs worth $593K as of Q1 2026.
  • Los Angeles Capital Management sold 6,489 BioAge Labs shares in Q1 2026, an estimated $125K.
  • BioAge Labs made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #816 holding.
  • Los Angeles Capital Management first reported a position in BioAge Labs in Q3 2025 and has held it in 3 quarters since.
  • Los Angeles Capital Management's BioAge Labs position peaked at $711K in Q3 2025.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.